Revascularization for unprotected left main disease: evolution of the evidence basis to redefine treatment standards.
暂无分享,去创建一个
P. Teirstein | G. Stone | Seung‐Jung Park | G. Dangas | S. Ellis | D. Kandzari | J. Popma | A. Colombo | J. Ormiston | C. Tommaso | Luis A. Guzmán | T. Bass | C. Tamburino
[1] Antonio Colombo,et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. , 2009, The New England journal of medicine.
[2] A. Kastrati,et al. Stent thrombosis after drug-eluting stent implantation: incidence, timing, and relation to discontinuation of clopidogrel therapy over a 4-year period. , 2009, European heart journal.
[3] D. Capodanno,et al. Usefulness of the SYNTAX Score for Predicting Clinical Outcome After Percutaneous Coronary Intervention of Unprotected Left Main Coronary Artery Disease , 2009, Circulation. Cardiovascular interventions.
[4] F. Alfonso. Left main coronary artery stenting: crossing the Rubicon. , 2009, Journal of the American College of Cardiology.
[5] A. Kastrati,et al. Paclitaxel- versus sirolimus-eluting stents for unprotected left main coronary artery disease. , 2009, Journal of the American College of Cardiology.
[6] S. de Servi,et al. Are drug-eluting stents superior to bare-metal stents in patients with unprotected non-bifurcational left main disease? Insights from a multicentre registry. , 2009, European heart journal.
[7] F. Verheugt,et al. Predictors of coronary stent thrombosis: the Dutch Stent Thrombosis Registry. , 2009, Journal of the American College of Cardiology.
[8] Young-Hak Kim,et al. Impact of Intravascular Ultrasound Guidance on Long-Term Mortality in Stenting for Unprotected Left Main Coronary Artery Stenosis , 2009, Circulation. Cardiovascular interventions.
[9] S. de Servi,et al. Temporal pattern of ischemic events in relation to dual antiplatelet therapy in patients with unprotected left main coronary artery stenosis undergoing percutaneous coronary intervention. , 2009, Journal of the American College of Cardiology.
[10] P. Fitzgerald,et al. 9-month clinical, angiographic, and intravascular ultrasound results of a prospective evaluation of the Axxess self-expanding biolimus A9-eluting stent in coronary bifurcation lesions: the DIVERGE (Drug-Eluting Stent Intervention for Treating Side Branches Effectively) study. , 2009, Journal of the American College of Cardiology.
[11] P. Teirstein. Percutaneous Revascularization Is the Preferred Strategy for Patients With Significant Left Main Coronary Stenosis , 2009, Circulation.
[12] Craig R. Smith. Surgery, not percutaneous revascularization, is the preferred strategy for patients with significant left main coronary stenosis. , 2009, Circulation.
[13] Y. Hayashi,et al. Antiplatelet Therapy and Stent Thrombosis After Sirolimus-Eluting Stent Implantation , 2009, Circulation.
[14] J. Spertus,et al. ACCF/SCAI/STS/AATS/AHA/ASNC 2009 Appropriateness Criteria for Coronary Revascularization: a report by the American College of Cardiology Foundation Appropriateness Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Th , 2009, Journal of the American College of Cardiology.
[15] D. Angiolillo,et al. CORONARY ARTERY DISEASE Original Studies Long-Term Clinical Outcomes After Drug-Eluting Stent Implantation in Unprotected Left Main Coronary Artery Disease , 2009 .
[16] Seung‐Jung Park,et al. Percutaneous Coronary Intervention With Stent Implantation Versus Coronary Artery Bypass Surgery for Treatment of Left Main Coronary Artery Disease: Is It Time to Change Guidelines? , 2009, Circulation. Cardiovascular interventions.
[17] S. de Servi,et al. Comparison of drug-eluting stents and bare-metal stents for the treatment of unprotected left main coronary artery disease in acute coronary syndromes. , 2009, The American journal of cardiology.
[18] J. Dery,et al. Nonrandomized Comparison of Coronary Artery Bypass Surgery and Percutaneous Coronary Intervention for the Treatment of Unprotected Left Main Coronary Artery Disease in Octogenarians , 2008, Circulation.
[19] S. de Servi,et al. Impact of Bifurcation Technique on 2-Year Clinical Outcomes in 773 Patients With Distal Unprotected Left Main Coronary Artery Stenosis Treated With Drug-Eluting Stents , 2008, Circulation. Cardiovascular interventions.
[20] S. de Servi,et al. Two-year clinical outcome with drug-eluting stents versus bare-metal stents in a real-world registry of unprotected left main coronary artery stenosis from the Italian Society of Invasive Cardiology. , 2008, The American journal of cardiology.
[21] E. Hannan,et al. Utilization and outcomes of unprotected left main coronary artery stenting and coronary artery bypass graft surgery. , 2008, The Annals of thoracic surgery.
[22] Seung‐Jung Park,et al. Stent thrombosis, clinical events, and influence of prolonged clopidogrel use after placement of drug-eluting stent data from an observational cohort study of drug-eluting versus bare-metal stents. , 2008, JACC. Cardiovascular interventions.
[23] P. Serruys,et al. Late and very late stent thrombosis following drug-eluting stent implantation in unprotected left main coronary artery: a multicentre registry. , 2008, European heart journal.
[24] I. Palacios,et al. Clinical Outcomes After Drug-Eluting Stent Implantation for Unprotected Left Main Coronary Artery Disease The DELFT ( Drug Eluting stent for LeFT main ) Registry , 2008 .
[25] I. Liu,et al. Long-term outcomes by clopidogrel duration and stent type in a diabetic population with de novo coronary artery lesions. , 2008, Journal of the American College of Cardiology.
[26] C. Chu,et al. Percutaneous coronary intervention versus coronary artery bypass graft surgery for the treatment of unprotected left main coronary artery stenosis: in-hospital and one year outcome after emergent and elective treatments. , 2008, International heart journal.
[27] C. Chu,et al. Percutaneous coronary intervention versus coronary artery bypass graft surgery for the treatment of unprotected left main coronary artery stenosis: in-hospital and one year outcome after emergent and elective treatments. , 2008, International heart journal.
[28] Young-Hak Kim,et al. Stents versus coronary-artery bypass grafting for left main coronary artery disease. , 2008, The New England journal of medicine.
[29] G. Stone,et al. Effectiveness of drug-eluting stent implantation for patients with unprotected left main coronary artery stenosis. , 2008, The American journal of cardiology.
[30] S. Yusuf,et al. Revascularization for unprotected left main stem coronary artery stenosis stenting or surgery. , 2008, Journal of the American College of Cardiology.
[31] S. Qiao,et al. Immediate and long-term outcomes of drug-eluting stent implantation for unprotected left main coronary artery disease: comparison with bare-metal stent implantation. , 2008, American heart journal.
[32] D. Dudek,et al. Acute and late outcomes of unprotected left main stenting in comparison with surgical revascularization. , 2008, Journal of the American College of Cardiology.
[33] P. Teirstein,et al. A collaborative systematic review and meta-analysis on 1278 patients undergoing percutaneous drug-eluting stenting for unprotected left main coronary artery disease. , 2008, American heart journal.
[34] S. Ellis,et al. Comparison of percutaneous versus surgical revascularization of severe unprotected left main coronary stenosis in matched patients. , 2008, The American journal of cardiology.
[35] H. Huikuri,et al. Coronary angioplasty in drug eluting stent era for the treatment of unprotected left main stenosis compared to coronary artery bypass grafting , 2008, Annals of medicine.
[36] S. de Servi,et al. A comparison between coronary artery bypass grafting surgery and drug eluting stent for the treatment of unprotected left main coronary artery disease in elderly patients (aged > or =75 years). , 2007, European heart journal.
[37] A. Íñiguez,et al. Comparison of drug-eluting stents versus surgery for unprotected left main coronary artery disease. , 2007, The American journal of cardiology.
[38] A. Colombo,et al. Incidence and Predictors of Drug-Eluting Stent Thrombosis During and After Discontinuation of Thienopyridine Treatment , 2007, Circulation.
[39] A. Erglis,et al. A randomized comparison of paclitaxel-eluting stents versus bare-metal stents for treatment of unprotected left main coronary artery stenosis. , 2007, Journal of the American College of Cardiology.
[40] P. Serruys,et al. Favorable Long-Term Outcome After Drug-Eluting Stent Implantation in Nonbifurcation Lesions That Involve Unprotected Left Main Coronary Artery: A Multicenter Registry , 2007, Circulation.
[41] David B Matchar,et al. Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. , 2007, JAMA.
[42] Seung‐Jung Park,et al. EuroSCORE as a predictor of death and myocardial infarction after unprotected left main coronary stenting. , 2006, The American journal of cardiology.
[43] G. Trevi,et al. Sirolimus-Eluting Stents vs Bare Metal Stents for the treatment of unprotected left main coronary artery stenosis. , 2006, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[44] P. Serruys,et al. Single-vessel versus bifurcation stenting for the treatment of distal left main coronary artery disease in the drug-eluting stenting era. Clinical and angiographic insights into the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) and Taxus-Stent Evaluated at Rotterdam C , 2006, American heart journal.
[45] I. Iakovou,et al. Elective versus provisional intraaortic balloon pumping in unprotected left main stenting. , 2006, American heart journal.
[46] W. B. Meijboom,et al. Multislice Spiral Computed Tomography for the Evaluation of Stent Patency After Left Main Coronary Artery Stenting: A Comparison With Conventional Coronary Angiography and Intravascular Ultrasound , 2006, Circulation.
[47] G. Parodi,et al. Drug‐eluting stent supported percutaneous coronary intervention for unprotected left main disease , 2006, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[48] A. Branzi,et al. Comparison between coronary angioplasty and coronary artery bypass surgery for the treatment of unprotected left main coronary artery stenosis (the Bologna Registry). , 2006, The American journal of cardiology.
[49] Seung‐Jung Park,et al. Comparison of simple and complex stenting techniques in the treatment of unprotected left main coronary artery bifurcation stenosis. , 2006, The American journal of cardiology.
[50] O. Alfieri,et al. Percutaneous Treatment With Drug-Eluting Stent Implantation Versus Bypass Surgery for Unprotected Left Main Stenosis: A Single-Center Experience , 2006, Circulation.
[51] P. Serruys,et al. Distal left main coronary disease is a major predictor of outcome in patients undergoing percutaneous intervention in the drug-eluting stent era: an integrated clinical and angiographic analysis based on the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) and Taxus-Sten , 2006, Journal of the American College of Cardiology.
[52] Ya‐Ling Han,et al. Efficacy of stenting for unprotected left main coronary artery disease in 297 patients. , 2006, Chinese medical journal.
[53] P. Teirstein,et al. Serial angiographic follow-up of sirolimus-eluting stents for unprotected left main coronary artery revascularization. , 2006, Journal of the American College of Cardiology.
[54] P. Shah,et al. Comparison of coronary artery bypass surgery with percutaneous coronary intervention with drug-eluting stents for unprotected left main coronary artery disease. , 2006, Journal of the American College of Cardiology.
[55] H. Bøtker,et al. Outcome of unprotected left main percutaneous coronary intervention in surgical low-risk, surgical high-risk, and acute myocardial infarction patients. , 2006, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[56] T. Lhermusier,et al. Clinical and angiographic outcome of paclitaxel-eluting stent implantation for unprotected left main coronary artery bifurcation narrowing. , 2006, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[57] Joseph P Ornato,et al. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to update the 2001 Guidelines for Percutaneous Coronary Intervention , 2006, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[58] Seung‐Jung Park. Inflammatory biomarkers for prediction of outcomes after unprotected left main coronary intervention. , 2005, Circulation.
[59] A. Branzi,et al. Preprocedural Levels of C-Reactive Protein and Leukocyte Counts Predict 9-Month Mortality After Coronary Angioplasty for the Treatment of Unprotected Left Main Coronary Artery Stenosis , 2005, Circulation.
[60] Byung Ok Kim,et al. Sirolimus- versus Paclitaxel-Eluting Stent Implantation for Unprotected Left Main Coronary Artery Stenosis , 2005, Cardiology.
[61] W. J. van der Giessen,et al. The Frontier stent registry: safety and feasibility of a novel dedicated stent for the treatment of bifurcation coronary artery lesions. , 2005, Journal of the American College of Cardiology.
[62] R. Califf. Stenting or surgery: an opportunity to do it right. , 2005, Journal of the American College of Cardiology.
[63] J. Schneider,et al. Technique of left main stenting is dependent on lesion location and distal branch protection , 2005, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[64] P. Serruys,et al. The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. , 2005, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[65] I. Iakovou,et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. , 2005, JAMA.
[66] P. Serruys,et al. Short- and Long-Term Clinical Outcome After Drug-Eluting Stent Implantation for the Percutaneous Treatment of Left Main Coronary Artery Disease: Insights From the Rapamycin-Eluting and Taxus Stent Evaluated At Rotterdam Cardiology Hospital Registries (RESEARCH and T-SEARCH) , 2005, Circulation.
[67] P. Serruys,et al. Comparison of early outcome of percutaneous coronary intervention for unprotected left main coronary artery disease in the drug-eluting stent era with versus without intravascular ultrasonic guidance. , 2005, The American journal of cardiology.
[68] I. Iakovou,et al. Early and Mid-Term Results of Drug-Eluting Stent Implantation in Unprotected Left Main , 2005, Circulation.
[69] Seung‐Jung Park,et al. Sirolimus-eluting stent implantation for unprotected left main coronary artery stenosis: comparison with bare metal stent implantation. , 2005, Journal of the American College of Cardiology.
[70] M. Leesar,et al. Correlations Between Fractional Flow Reserve and Intravascular Ultrasound in Patients With an Ambiguous Left Main Coronary Artery Stenosis , 2004, Circulation.
[71] M. Pan,et al. Rapamycin-eluting stents for the treatment of unprotected left main coronary disease. , 2004, American heart journal.
[72] J. Koolen,et al. Value of fractional flow reserve in making decisions about bypass surgery for equivocal left main coronary artery disease , 2001, Heart.
[73] S. Lemeshow,et al. European system for cardiac operative risk evaluation (EuroSCORE). , 1999, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[74] A. Bernstein,et al. A method of uniform stratification of risk for evaluating the results of surgery in acquired adult heart disease. , 1989, Circulation.
[75] J. Fajadet,et al. Twelve month clinical and angiographic outcome after stenting of unprotected left main coronary artery stenosis with paclitaxel-eluting stents--results of the multicentre FRIEND registry. , 2009, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[76] Frederick A. Masoudi,et al. ACCF/SCAI/STS/MTS/AHA/ASNC 2009 Appropriateness Criteria for Coronary Revascularization. Commentary , 2009 .
[77] Joseph P Ornato,et al. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). , 2006, Journal of the American College of Cardiology.
[78] S. Nashef,et al. Eurp-pean system for cardiac operative risk evaluation (Euro SCORE) , 1999 .
[79] R. Califf,et al. Technical feasibility , safety , and clinical outcome of stenting of unprotected left main coronary artery bifurcation narrowing , 2022 .